Series B funding round for Vivace Therapeutics raising $25M in June 2017
Series B funding round for Vivace Therapeutics raising $25M in June 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$60M
Top Valuation
-
Vivace Therapeutics raised $25M in a Series B round.
The round was announced on 06/01/17.